Exact Mass: 474.1445
Exact Mass Matches: 474.1445
Found 153 metabolites which its exact mass value is equals to given mass value 474.1445
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
trans-Caffeic acid [apiosyl-(1->6)-glucosyl] ester
trans-Caffeic acid [apiosyl-(1->6)-glucosyl] ester is found in herbs and spices. trans-Caffeic acid [apiosyl-(1->6)-glucosyl] ester is a constituent of Salvia officinalis (sage). Constituent of Salvia officinalis (sage). trans-Caffeic acid [apiosyl-(1->6)-glucosyl] ester is found in herbs and spices.
Enterolactone 3'-glucuronide
Enterolactone 3-glucuronide is a lignan metabolite produced in the liver. Enterolactone glucuronide is a potential urinary biomarker of whole grain intake (PMID: 23307617).
Enterolactone 3'-glucuronide
Enterolactone 3-glucuronide is a lignan metabolite produced in the liver. Enterolactone glucuronide is a potential urinary biomarker of whole grain intake (PMID: 23307617).
4,5-Dihydro-11,5-dihydroxy-4-methoxytephrosin
A member of the class of rotenones that is 4,5-dihydrotephrosin substituted by hydroxy groups at positions 11 and 5 and a methoxy group at position 4. It is isolated from the stems of Tephrosia toxicaria and exhibits antineoplastic activity.
9beta-Acetoxy-9beta-(5-acetoxy-tiglinoyloxy)-2-oxo-ludartin
7,8-trans-8,8-trans-7,8-trans-7,7-bis(5-methoxy-3,4-methylenedioxyphenyl)-8-acetoxymethyl-8-hydroxymethyltetrahydrofuran
5-methoxyphthalide 7-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside|5-Methoxyphthalide 7-O-??-xylopyranosyl-(1鈥樏傗垎6)-??-glucopyranoside
(1RS,2SR)-1,2-dihydro-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-6,8-dimethoxynaphthalene-2,3-dicarboxylic acid dimethyl ester|dimethyl (?)-thomasidioate|thomasidioic acid dimethyl ester|trans-thomasidioic acid dimethyl ester
(2R)-2-[(4-hydroxyphenyl)methyl]-3-[4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2H-furan-5-one
2-(benzoyloxymethyl)phenyl (3,6-di-O-acetyl)-beta-D-glucopyranoside
dimethyl (E,E)-4,4?-dihydroxy-3,3?,5,5?-tetramethoxylign-7,7?-dien-9,9?-dioate
8alpha-(5-acetoxysenecioyloxy)-3-oxo-1-desoxy-1,2-dehydrohirsutinolide-13-O-acetate
Cys Asp His Thr
Cys Asp Thr His
Cys Glu His Ser
Cys Glu Ser His
Cys His Asp Thr
Cys His Glu Ser
Cys His Ser Glu
Cys His Thr Asp
Cys Ser Glu His
Cys Ser His Glu
Cys Thr Asp His
Cys Thr His Asp
Asp Cys His Thr
Asp Cys Thr His
Asp His Cys Thr
Asp His Thr Cys
Asp Thr Cys His
Asp Thr His Cys
Glu Cys His Ser
Glu Cys Ser His
Glu His Cys Ser
Glu His Ser Cys
Glu Ser Cys His
Glu Ser His Cys
His Cys Asp Thr
His Cys Glu Ser
His Cys Ser Glu
His Cys Thr Asp
His Asp Cys Thr
His Asp Thr Cys
His Glu Cys Ser
His Glu Ser Cys
His Ser Cys Glu
His Ser Glu Cys
His Thr Cys Asp
His Thr Asp Cys
Ser Cys Glu His
Ser Cys His Glu
Ser Glu Cys His
Ser Glu His Cys
Ser His Cys Glu
Ser His Glu Cys
Thr Cys Asp His
Thr Cys His Asp
Thr Asp Cys His
Thr Asp His Cys
Thr His Cys Asp
Thr His Asp Cys
trans-Caffeic acid [apiosyl-(1->6)-glucosyl] ester
Methyl 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucopyranoside
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-tetrahydro-6-(hydroxymethyl)-2-methoxy-2H-pyran-3,4,5-triol
4-[[(1E)-2-(4-Chlorophenyl)ethenyl]sulfonyl]-1-[[1-(4-pyridinyl)-4-piperidinyl]methyl]piperazinone
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoyl]oxyoxane-2-carboxylic acid
3-[4-(4-Morpholinylsulfonyl)phenyl]propanoic acid [2-(4-acetylanilino)-2-oxoethyl] ester
2-[(2S,4aS,12aS)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2S,4aR,12aR)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2S,4aR,12aS)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2S,4aS,12aR)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2R,4aS,12aS)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2R,4aR,12aR)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
2-[(2R,4aR,12aS)-5-methyl-8-[(2-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid
[2-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] butanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] pentanoate
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] hexanoate
1,2-dibutyryl-sn-glycero-3-phospho-(1D-myo-inositol)
A 1-phosphatidyl-1D-myo-inositol in which the two phosphatidyl acyl groups are specified as butanoyl.
6,11,14-trihydroxy-5,17,18-trimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,9,11,15(20),16,18-hexaen-13-one
methyl 2-[(5z)-9-(acetyloxy)-5-(2-methoxy-2-oxoethylidene)-7,8-dimethyl-2,13,15-trioxatetracyclo[8.6.1.0⁴,¹⁷.0¹²,¹⁶]heptadeca-1(17),10,12(16)-trien-4-yl]-2-oxoacetate
2,3-dimethyl 7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-6,8-dimethoxy-1,2-dihydronaphthalene-2,3-dicarboxylate
[4-(hydroxymethyl)-2,5-bis(7-methoxy-2h-1,3-benzodioxol-5-yl)oxolan-3-yl]methyl acetate
anticancerrotenoid pmv70p691-036
{"Ingredient_id": "HBIN016352","Ingredient_name": "anticancerrotenoid pmv70p691-036","Alias": "NA","Ingredient_formula": "C24H26O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1436","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}